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Abstract
Objectives: Prostate	cancer,	after	the	phase	of	androgen	dependence,	may	progress	
to	the	castration‐resistant	prostate	cancer	(CRPC)	stage,	with	resistance	to	standard	
therapies.	Vitamin	E‐derived	tocotrienols	(TTs)	possess	a	significant	antitumour	ac‐
tivity.	Here,	we	evaluated	the	anti‐cancer	properties	of	δ‐TT	in	CRPC	cells	(PC3	and	
DU145)	and	the	related	mechanisms	of	action.
Materials and methods: MTT,	Trypan	blue	and	colony	formation	assays	were	used	to	
assess	cell	viability/cell	death/cytotoxicity.	Western	blot,	 immunofluorescence	and	
MTT	 analyses	 were	 utilized	 to	 investigate	 apoptosis,	 ER	 stress	 and	 autophagy.	
Morphological changes were investigated by light and transmission electron 
microscopy.
Results: We demonstrated that δ‐TT exerts a cytotoxic/proapoptotic activity in 
CRPC	cells.	We	found	that	in	PC3	cells:	(a)	δ‐TT triggers both the endoplasmic reticu‐
lum	(ER)	stress	and	autophagy	pathways;	(b)	autophagy	induction	is	related	to	the	ER	
stress,	and	this	ER	stress/autophagy	axis	is	involved	in	the	antitumour	activity	of	δ‐
TT;	in	autophagy‐defective	DU145	cells,	only	the	ER	stress	pathway	is	involved	in	the	
proapoptotic effects of δ‐TT;	(c)	in	both	CRPC	cell	lines,	δ‐TT also induces an intense 
vacuolation	prevented	by	the	ER	stress	inhibitor	salubrinal	and	the	protein	synthesis	
inhibitor	cycloheximide,	together	with	increased	levels	of	phosphorylated	JNK	and	
p38,	supporting	the	induction	of	paraptosis	by	δ‐TT.
Conclusions: These	 data	 demonstrate	 that	 apoptosis,	 involving	 ER	 stress	 and	 au‐
tophagy	(in	autophagy	positive	PC3	cells),	and	paraptosis	are	involved	in	the	anti‐can‐
cer activity of δ‐TT in CRPC cells.
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1  | INTRODUC TION
Prostate	cancer	 (PCa)	 represents	the	third	cause	of	cancer‐related	
deaths among men in the Western countries.1	Androgen‐deprivation	
therapy	(GnRH	agonists,	either	alone	or	in	combination	with	an	an‐
tiandrogen)	represents	the	treatment	of	choice	for	this	pathology.2,3 
However,	the	tumour	frequently	progresses	towards	a	condition	of	
castration	 resistance	 (castration‐resistant	 prostate	 cancer,	 CRPC)	
for which the therapeutic options are limited.5,6
Several natural compounds were reported to possess anti‐can‐
cer properties7	by	inducing	apoptosis,	through	modulation	of	intra‐
cellular	 pathways	 including	 endoplasmic	 reticulum	 (ER)	 stress	 and	
autophagy.8,9
Cells react to severe stress conditions by accumulating mis‐
folded	proteins	 in	the	ER,	 leading	to	dissociation	from	the	chaper‐
one	BiP	(immunoglobulin	heavy‐chain‐binding	protein,	GRP78)	and	
activation	of	three	stress	sensors:	PERK	(double‐stranded	RNA‐de‐
pendent	protein	kinase	PKR‐like	ER	kinase),	ATF6	 (activating	 tran‐
scription	factor	6)	and	IRE1α	(inositol‐requiring	enzyme	1α).	Each	of	
these proteins couples to a specific intracellular pathway converging 
to apoptosis.14,15	 The	 transcription	 factor	 CHOP	 (C/EBP	 homolo‐
gous	protein,	also	known	as	GADD153)	plays	a	key	 role	 in	 the	ER	
stress‐related apoptosis pathway.
Autophagy	consists	of	 the	degradation/recycling	of	damaged	
cytoplasmic	proteins	and	organelles	that	are	sequestered	in	auto‐
phagosomes and then degraded in autophagolysosomes. Several 
markers	of	the	autophagic	phases,	such	as	LC3‐II	(the	phosphati‐
dylethanolamine‐conjugated	form	of	LC3	microtubule‐associated	
protein	 1AB‐light	 chain),	 and	 sequestosome	 1/p62	 (SQSTM1/
p62)16	were	identified.	Autophagy	is	involved	both	in	suppression	
of cancer growth and in development of drug resistance in cancer 
cells.17	 There	 is	 now	evidence	 connecting	 the	ER	 stress‐autoph‐
agy	axis	with	apoptosis,	representing	a	molecular	target	of	cancer	
treatments.8
Non‐canonical	 cell	 death	 mechanisms	 are	 also	 involved	 in	
natural compounds anti‐cancer activity.18,19 Paraptosis is a pro‐
grammed cell death characterized by cytoplasmic vacuolation 
resulting	from	mitochondrial	and/or	ER	swelling	and	requiring	pro‐
tein synthesis.21
Vitamin	E	is	composed	of	two	groups	of	compounds,	tocopherols	
(TPs)	and	tocotrienols	(TTs);	each	group	consists	of	four	isomers:	α,	
β,	γ and δ.	TTs	(but	not	TPs)	have	attracted	interest	for	their	health‐
promoting	properties,	such	as	anti‐cancer	activity.	δ‐ and γ‐TT were 
reported to exert anti‐cancer activities through the modulation of 
different intracellular pathways.22,23 The bioavailability/safety of 
these compounds was demonstrated in healthy subjects25,26 and in 
cancer patients.27
Here,	 we	 dissected	 the	 antitumour	 effects	 of	 δ‐TT in CRPC 
cells	 by	 exploring	 the	 involvement	 of	 the	 ER	 stress‐autophagy	
axis in this activity; we also investigated the possible involvement 
of	 non‐canonical	 programmed	 cell	 deaths	 (ie	 paraptosis)	 in	 its	
effects.
2  | MATERIAL S AND METHODS
2.1 | Chemicals
δ‐TT	was	purified	from	a	commercial	extract	of	Annatto	(Bixa orel‐
lana	L.)	seeds	(American	River	Nutrition	Inc,	Hadley,	MA,	USA).28
Primary	antibodies	against:	caspase	3	(9656),	cleaved	caspase	
3	 (9664),	 PARP	 (9542),	BiP	 (3177),	 eIF2α	 (5324),	 p‐eIF2α	 (3398),	
ATF4	(11815),	CHOP	(2895),	 IRE1α	 (3294),	PDI	(3501)	were	from	
Cell	 Signaling	 Technology	 Inc,	 Boston,	 MA,	 USA;	 SQSTM1/p62	
(PA5‐20839)	was	from	Thermo	Fisher	Scientific,	Rodano,	Milano,	
Italy;	 LC3	 (L8918);	 JNK,	 p38	 and	 α‐tubulin	 (T6199)	 were	 from	
Sigma‐Aldrich,	Milano,	Italy,	and	cytochrome	c	(sc‐13560)	was	from	
Santa	Cruz	Biotechnology	Inc,	Santa	Cruz,	CA,	USA.	Horseradish	
peroxidase‐conjugated secondary antibody and enhanced chemi‐
luminescence	reagents	were	from	Cyanagen	(Bologna,	Italy).	Alexa	
Fluor	488	and	594	secondary	antibodies	were	from	Thermo	Fisher	
Scientific.
Z‐VAD‐FMK	 (the	 pan‐caspase	 inhibitor;	 FMK001)	 was	 from	
R&D	System	Inc	(Minneapolis,	MN).	The	ER	stress	inhibitors	salu‐
brinal	(S)	and	4‐PBA	(4‐phenylbutyrate),	the	autophagy	inhibitors	
CQ	 (chloroquine)	 and	 Baf	 (bafilomycin),	 the	 translation	 inhibitor	
cycloheximide,	 and	 analytical	 grade	 solvents	 were	 from	 Sigma‐
Aldrich;	3‐MA	(3‐methyladenine)	was	from	Selleckchem	(Munich,	
Germany).
2.2 | Cell lines and cell culture
Normal	 prostate	 epithelial	 RWPE‐1	 (provided	 by	 Dr	 N.	 Zaffaroni;	
IRCCS,	National	Institute	of	Cancer,	Milano,	Italy)	and	cancer	(DU145	
and	 PC3)	 cell	 lines	 were	 from	 American	 Type	 Culture	 Collection	
(ATCC,	Manassas,	VA,	USA).	RWPE‐1	cells	were	cultured	in	keratino‐
cyte‐SFM	medium	supplemented	with	Bovine	Pituitary	Extracts	and	
EGF	 (2.5	μM)	 (Thermo	 Fisher	 Scientific),	 DU145	 and	 PC3	 cells	 in	
RPMI	medium	supplemented	with	FBS	(7.5%	and	5%	respectively),	
F I G U R E  1   δ‐TT	decreases	cell	viability	and	exerts	a	cytotoxic	effect	on	DU145	and	PC3	prostate	cancer	cells.	A,	RWPE‐1	normal	
epithelial	prostate	cells	and	DU145	and	PC3	prostate	cancer	cells	were	treated	with	δ‐TT	(5‐20	μg/mL)	for	24	h.	Cell	viability	was	then	
evaluated	by	MTT	assay.	The	IC50 values were 2.91 × 10
−5	M	and	3.22	×	10−5	M	for	DU145	and	PC3	cells,	respectively.	B,	Prostate	cancer	
cells were treated with δ‐TT	(5‐20	μg/mL)	for	24	h.	Total,	live	and	dead	cells	were	evaluated	by	Trypan	blue	exclusion	assay.	C,	DU145	and	
PC3	cancer	cells	were	treated	with	δ‐TT	(15	μg/mL)	for	36‐72	h.	Cell	viability	was	then	evaluated	by	MTT	assay.	D,	Prostate	cancer	cells	
were treated with δ‐TT	(15	μg/mL)	for	48	h	and	then,	after	withdrawal	of	the	treatment,	were	left	to	grow	for	11‐12	d,	dependently	on	the	
cell	line‐specific	proliferation	rate.	A	colony	formation	assay	was	performed	to	evaluate	the	ability	of	the	cells	to	form	proliferating	colonies	
(dimensions	of	colonies)	and	the	survival	of	colony‐forming	cells	(number	of	colonies).	Each	experiment	was	repeated	three	times.	Data	in	
(A‐C)	represent	mean	values	±	SEM	and	were	analysed	by	Dunnet's	test	after	one‐way	analysis	of	variance.	*P	<	0.05	vs	0,	controls	(vehicle)
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F I G U R E  2   δ‐TT	triggers	apoptosis	in	DU145	and	PC3	prostate	cancer	cells.	A,	DU145	and	PC3	cells	were	treated	with	δ‐TT	(5‐20	μg/
mL)	for	24	h	(left	panels)	or	with	δ‐TT	(15	μg/mL)	for	6‐24	h	(right	panels).	Western	blot	analysis	was	carried	out	to	analyse	the	expression	
levels	of	cleaved	caspase	3	(ie	active)	and	PARP.	Tubulin	expression	was	evaluated	as	a	loading	control.	0	and	C,	controls	(vehicle).	One	
representative	of	three	different	experiments,	for	each	of	the	analyses	performed,	is	shown.	B,	DU145	and	PC3	cells	were	treated	with	δ‐TT 
(15	μg/mL)	for	18	h;	the	intracellular	localization	of	cytochrome	c	was	then	evaluated	by	immunofluorescence	analysis.	One	representative	
of three experiments performed is shown. Scale bars are 20 μm. The arrow indicates the cytochrome c‐mitochondrial colocalization in 
controls	cells.	C,	To	confirm	the	involvement	of	apoptosis	in	the	antitumour	activity	of	δ‐TT,	DU145	and	PC3	cells	were	treated	with	the	
pan‐caspase	inhibitor	Z‐VAD‐FMK	(50	μM)	for	4	h	before	the	tocotrienol	(15	μg/mL	for	24	h).	Cell	viability	was	then	evaluated	by	MTT	
assay.	Each	experiment	was	repeated	three	times.	Data	represent	mean	values	±	SEM	and	were	analysed	by	Bonferroni's	test	after	one‐way	
analysis of variance. *P	<	0.05	vs	controls	(vehicle).	♦P < 0.05 vs δ‐TT‐treated cells
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glutamine and antibiotics. Cells were cultured in humidified atmos‐
phere	of	5%	CO2/95%	air	at	37°C.
2.3 | MTT viability assay
Cells	 were	 seeded	 at	 a	 density	 of	 3	×	104	cells/well	 in	 24‐well	
plates	 for	 24	hours	 and	 then	 exposed	 to	 the	 specific	 com‐
pounds.	 After	 each	 treatment,	 cell	 viability	 was	 determined	 by	
3‐(4,5‐dimethylthiazole‐2‐yl)‐2,5‐diphenyltetrazolium	 bromide	
(MTT)	assay,	as	described.29
2.4 | Trypan blue exclusion assay
Cells	were	plated	(5	×	104	cells/dish)	in	6‐cm	dishes.	After	48	hours,	
cells were treated with δ‐TT	 (5‐20	μg/mL,	24	hours).	Adherent	 (vi‐
able)	and	floating	(dead)	cells	were	harvested,	stained	with	Trypan	
F I G U R E  3   δ‐TT	triggers	ER	stress	in	
DU145	and	PC3	prostate	cancer	cells.	A,	
DU145	and	PC3	cells	were	treated	with	
δ‐TT	(15	μg/mL)	for	1‐24	h.	Western	blot	
analysis was performed to investigate 
the	expression	levels	of	ER	stress‐related	
proteins	(BiP,	eIF2α,	p‐	eIF2α,	ATF4,	
CHOP,	IRE1α,	PDI).	Tubulin	expression	
was	evaluated	as	a	loading	control.	B,	
DU145	and	PC3	cells	were	treated	with	
δ‐TT	(15	μg/mL)	for	18	h.	The	expression	
levels and intracellular localization of 
the key transcription factors involved 
in	the	ER	stress‐mediated	apoptosis	
(ATF4	and	CHOP)	were	evaluated	by	
immunofluorescence	analysis.	C,	controls	
(vehicle).	Scale	bars	are	20	μm.	C,	CRPC	
cells	were	pretreated	with	the	ER	stress	
inhibitors	salubrinal	(S;	20	μM)	or	4‐PBA	
(2	mM),	for	4	and	1	h,	respectively,	before	
treatment with δ‐TT	(15	μg/mL)	for	24	h.	
The effects of the treatments were 
analysed	on	CHOP	and	ATF	expression	
levels by Western blot. Tubulin expression 
was evaluated as a loading control. 
One	representative	of	three	different	
experiments performed is shown
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blue	 0.4%	 (1:1	 v/v)	 and	 counted	 by	 Luna	 automated	 cell	 counter	
(Logos	Biosystems,	Annandale,	VA,	USA).
2.5 | Colony formation assay
Cells	were	seeded	(100‐250	cells/well,	depending	on	the	cell	type)	
in	6‐well	 plates.	After	 each	 treatment,	 a	 colony	 formation	 assay	
was performed to assess dimensions and numbers of colonies. 
Colonies	were	fixed	with	70%	methanol	and	stained	with	Crystal	
Violet	0.15%.	Images	of	stained	colonies	were	captured	by	a	Nikon	
photo camera.
2.6 | Western blot assay
Cells were seeded at 5 × 105	cells/dish	 in	 10‐cm	 dishes.	 After	
each	 treatment,	 cells	 were	 lysed	 in	 RIPA	 buffer;	 protein	 prepara‐
tions	 (15‐40	μg)	 were	 resolved	 on	 SDS‐PAGE	 and	 transferred	 to	
nitrocellulose	 (or	 PVDF	 for	 the	Western	 blot	 of	 LC3)	membranes.	
Membranes were incubated with the specific primary antibodies. 
Detection	was	done	using	horseradish	peroxidase‐conjugated	sec‐
ondary	antibodies	and	enhanced	chemiluminescence	 (Westar	Etac	
Ultra	 2.0,	 XLS075,0100;	 Cyanagen	 Srl).	 Tubulin	 was	 utilized	 as	 a	
loading control.
2.7 | Immunofluorescence assay
Cells	 were	 seeded	 at	 3	×	104	cells/well	 in	 24‐well	 plates	 on	 pol‐
ylysine‐coated	 13‐mm	 coverslips	 for	 48	hours	 before	 treatments.	
After	each	treatment,	cells	were	fixed	and	stained	with	the	specific	
primary	 antibodies,	 followed	 by	 secondary	 antibodies.	 Labelled	
cells	were	examined	under	a	Zeiss	Axiovert	200	microscope	with	a	
63	×	1.4	objective	lens	linked	to	a	Coolsnap	Es	CCD	camera	(Roper	
Scientific‐Crisel	Instruments,	Roma,	Italy).
2.8 | Morphological analysis
Cells	were	 seeded	at	3	or	4	×	104	 cells/dish	 in	6‐cm	dishes,	 re‐
spectively,	 and	 treated	 with	 δ‐TT	 (15	μg/mL	 for	 18	hours).	
Cytoplasmic vacuolation was analysed by light microscopy from 
different	 fields	 under	 a	 Zeiss	 Axiovert	 200	 microscope	 with	
a	 32	×	0.4	 objective	 lens	 linked	 to	 a	 Coolsnap	 Es	 CCD	 camera	
(Roper	Scientific‐Crisel	 Instruments).	For	TEM	analysis,	cell	pel‐
lets	were	 fixed	 over	 night	 in	 a	 solution	 containing	 2%	 of	 para‐
formaldehyde	and	2%	glutaraldehyde	in	0.1	M	sodium	cacodylate	
buffer	(pH	7.3).	Samples	were	post‐fixed	in	1%	osmium	tetroxide	
in	cacodylate	buffer	at	0°C	for	90	minutes,	washed,	dehydrated	
and	 embedded	 in	 Epon‐Araldite	 resin.	 Ultrathin	 sections	 were	
F I G U R E  4  ER	stress	mediates	the	
proapoptotic activity of δ‐TT	in	DU145	
and	PC3	prostate	cancer	cells.	DU145	and	
PC3	cells	were	pretreated	with	the	ER	
stress	inhibitors	salubrinal	(S;	20	μM)	or	
4‐PBA	(2	mM),	for	4	and	1	h,	respectively,	
before treatment with δ‐TT	(15	μg/mL)	
for	24	h.	A,	The	expression	levels	of	
cleaved	(ie	active)	caspase	3	and	PARP	
were evaluated by Western blot analysis. 
Tubulin expression was evaluated as a 
loading	control.	One	representative	of	
three different experiments performed 
is	shown.	B,	Cell	viability	was	assessed	
by	MTT	assay.	Each	experiment	was	
repeated	three	times.	Data	represent	
mean	values	±	SEM	and	were	analysed	by	
Bonferroni's	test	after	one‐way	analysis	
of variance. *P	<	0.05	vs	controls	(vehicle).	
♦P < 0.05 vs δ‐TT‐treated cells
     |  7 of 15FONTANA eT Al.
cut	 by	 a	 Leica	 Supernova	 ultramicrotome	 (Reichert	 Ultracut	 E)	
and	 stained	with	 lead	citrate.	TEM	was	performed	with	a	Zeiss	
EM10	electron	microscope.
2.9 | Statistical analysis
Statistical analysis was performed with a statistic package 
(GraphPad	Prism5,	GraphPad	Software	San	Diego,	CA,	USA).	Data	
are	represented	as	the	mean	±	SEM	of	three‐four	independent	ex‐
periments.	Differences	between	groups	were	assessed	by	one‐way	
analysis	of	variance	(ANOVA)	followed	by	Dunnet's	or	Bonferroni's	
test.	A	P value <0.05 was considered statistically significant.
3  | RESULTS
3.1 | δ‐TT reduces cells viability and exerts a 
cytotoxic effect in prostate cancer cells
DU145	 and	 PC3	 or	 normal	 RWPE‐1	 prostate	 epithelial	 cells	 were	
treated with δ‐TT	(5‐20	μg/mL,	24	hours);	cell	viability	was	measured	
F I G U R E  5   δ‐TT	triggers	autophagy	in	PC3,	but	not	in	DU145,	prostate	cancer	cells.	DU145	and	PC3	cells	were	treated	with	δ‐TT	(15	μg/
mL)	for	1‐24	h.	A,	Western	blot	analysis	was	performed	to	investigate	the	expression	levels	of	autophagy‐related	proteins	(LC3‐II/LC3‐I,	
SQSTM1/p62).	Tubulin	expression	was	evaluated	as	a	loading	control.	B,	The	expression	levels	and	intracellular	localization	of	LC3	and	
SQSTM1/p62	were	evaluated	by	immunofluorescence.	One	representative	of	three	different	experiments	performed	is	shown.	C,	controls	
(vehicle).	Scale	bars	are	20	μm
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F I G U R E  6  Autophagy,	related	to	ER	stress,	mediates	the	antitumour	activity	of	δ‐TT	in	PC3	prostate	cancer	cells.	A,	Cells	were	treated	
with δ‐TT	(15	μM)	for	18	h	and	TEM	images	were	selected.	Left	panel	is	a	TEM	image	of	control	cells.	Boxed	area	indicates	the	presence,	
in δ‐TT‐treated	cells,	of	autophagosomes	(middle	panel)	that	can	localize	at	the	lysosomal	level	forming	autophagolysosomes	(right	panel).	
Scale bars are 2 and 0.7 μm	for	photographs	in	boxed	areas.	B	and	C,	Cells	were	treated	with	δ‐TT	(15	μg/mL)	for	24	h	in	the	presence	of	
either	the	inhibitor	of	early	stage	autophagy	3‐MA	(10	mM)	(B)	or	the	inhibitors	of	late	stage	autophagy	CQ	(10	μM)	and	Baf	(10	nM)	(C).	The	
LC3‐II/LC3‐I	ratio	and	SQSTM1/p62	levels	were	evaluated	by	Western	blot	analysis.	D	and	E,	Cells	were	pretreated	with	the	two	ER	stress	
inhibitors	salubrinal	(S;	20	μM)	for	4	h,	or	4‐PBA	(2	mM)	for	1	h,	and	then	with	δ‐TT	(15	μg/mL)	for	18	h.	The	LC3‐II/LC3‐I	ratio	and	SQSTM1/
p62	levels	were	evaluated	by	Western	blot	analysis.	F	and	G,	PC3	cells	were	pretreated	with	3‐MA	(10	mM)	for	4	h	before	tocotrienol	
treatment	(15	μg/mL)	for	24	h.	The	effects	of	the	treatment	were	analysed	on	the	expression	of	apoptosis‐related	markers,	by	Western	blot	
(F)	as	well	as	on	cell	viability,	by	MTT	assay	(G).	For	Western	blot	analyses,	one	representative	of	three	different	experiments	performed	is	
shown.	For	MTT	assay,	each	experiment	was	repeated	three	times	and	data	represent	mean	values	±	SEM	and	were	analysed	by	Bonferroni's	
test after one‐way analysis of variance. *P	<	0.05	vs	C,	controls	(vehicle).	♦P < 0.05 vs δ‐TT‐treated cells
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(MTT	assay).	δ‐TT decreased the number of viable CRPC cells in a 
dose‐dependent way being significantly effective at 10‐20 μg/mL.	
The	 IC50 values were 2.91 × 10
−5	M	and	3.22	×	10−5	M	for	DU145	
and	PC3	cells,	respectively.	The	same	treatment	affected	the	growth	
of	 RWPE‐1	 cells	 only	 slightly	 and	 at	 the	 highest	 dose	 (20	μg/mL;	
Figure	1A).
CRPC cells were treated with δ‐TT	(5‐20	μg/mL,	24	hours),	then	
dying	 (floating)	 and	 living	 (adherent)	 cells	were	harvested,	 stained	
with	Trypan	blue	and	counted.	In	both	cell	 lines,	δ‐TT	significantly,	
and	dose‐dependently,	decreased	the	number	of	viable	cells	and	in‐
creased	the	number	of	dead	cells	(Figure	1B).
To	 obtain	 growth	 curve	 kinetics	 beyond	 24	hours,	 CRPC	 cells	
were treated with δ‐TT	 (15	μg/mL,	 36‐72	hours);	 cell	 viability	was	
then measured. δ‐TT significantly and dose‐dependently decreased 
the	number	of	viable	cells	at	each	time	point	(Figure	1C),	confirming	
results	reported	in	Figure	1A.
The cytotoxic activity of δ‐TT was investigated by colony forma‐
tion assay. CRPC cells were treated with δ‐TT	(15	μg/mL,	48	hours)	
and	left	to	grow	for	11‐12	days	in	the	absence	of	the	treatment,	ac‐
cording	 to	 the	 cell	 line‐specific	 proliferation	 rate.	We	 analysed	 (a)	
the	ability	of	the	cells	to	form	colonies	(dimensions	of	colonies)	and	
(b)	the	survival	of	colony‐forming	cells	(number	of	colonies).	We	ob‐
served that untreated cells grew forming colonies while none of δ‐
TT‐treated	cells	survived	to	the	treatment;	moreover,	the	ability	of	
the	cells	to	form	colonies	was	prevented	by	the	treatment,	support‐
ing a cytotoxic effect of δ‐TT	(Figure	1D).
3.2 | δ‐TT triggers apoptosis in prostate cancer cells
DU145	and	PC3	cells	were	treated	with	δ‐TT	(5‐20	μg/mL,	24	hours);	
the	levels	of	active	(cleaved)	caspase	3	were	increased	by	δ‐TT treat‐
ment	 (15	 and	 20	μg/mL),	 while	 cleaved	 PARP	 levels	 increased	 at	
the doses of 10‐20 μg/mL,	in	both	cell	lines	(Figure	2A,	left	panels).	
Moreover,	active	caspase	3	and	PARP	 levels	 increased	 in	both	cell	
lines	at	18‐24	h	of	treatment	(15	μg/mL)	(Figure	2A,	right	panels).
Immunofluorescence	 studies	 were	 performed	 to	 confirm	 the	
involvement of intrinsic apoptosis in the activity of δ‐TT	 (15	μg/
mL,	18	hours).	It	was	observed	that,	after	treatment,	cytochrome	c 
was diffused in the cytosol and no overlapping with mitochondria 
could be observed demonstrating its release from mitochondria 
(Figure	2B).
CRPC	cells	were	treated	with	Z‐VAD‐FMK,	the	pan‐caspase	in‐
hibitor	(50	μM,	4	hours)	before	the	treatment	with	δ‐TT	(15	μg/mL,	
24	hours).	 Cell	 viability	was	 significantly	 reduced	 by	 δ‐TT.	 Z‐VAD‐
FMK,	given	alone,	did	not	modify	cell	viability;	however,	pre‐treat‐
ment	 of	 both	 cell	 lines	with	 Z‐VAD‐FMK	 significantly	 (even	 if	 not	
completely)	reverted	the	antitumour	effect	of	δ‐TT	(Figure	2C).
3.3 | δ‐TT triggers ER stress in prostate cancer cells
CRPC cells were treated with δ‐TT	(15	μg/mL,	1‐24	hours).	The	ex‐
pression	of	ER	stress	markers	(BiP,	eIF2α,	p‐eIF2α,	IRE1α,	PDI)	and	
markers	 of	 ER	 stress‐related	 apoptosis	 (ATF4	 and	 CHOP)	 were	
analysed by Western blotting. δ‐TT increased the levels of BiP 
(18‐24	hours)	in	DU145	and	PC3	cells.	The	levels	of	p‐eIF2α	(but	not	
eIF2α)	 increased	 in	DU145	 (6‐18	hours)	and	PC3	cells	 (1‐24	hours).	
The	expression	of	IRE1α	was	increased	at	18‐24	hours	in	DU145	and	
at	1‐24	hours	in	PC3	cells.	On	the	other	hand,	the	levels	of	the	chap‐
erone	protein	PDI	was	unaffected	in	both	cell	lines.	Finally,	ATF4	lev‐
els	were	increased	at	18‐24	hours	in	DU145	cells	and	at	6‐24	hours	
in	PC3	cells,	while	those	of	CHOP	increased	at	18‐24	hours	in	both	
CRPC	cell	lines	(Figure	3A).
The intracellular localization of the transcription factors in‐
volved	in	the	ER	stress‐mediated	apoptosis	was	analysed	in	CRPC	
cells treated with δ‐TT	 (15	μg/mL,	 18	hours)	 by	 immunofluo‐
rescence.	 In	untreated	 cells,	 the	 levels	of	ATF4	and	CHOP	were	
almost	undetectable	in	both	cells	lines	(confirming	the	results	ob‐
tained	by	Western	blot).	δ‐TT treatment triggered the expression 
of these transcription factors together with their nuclear localiza‐
tion	 (overlapping	 staining	 between	TRITC‐conjugated	 antibodies	
and	DAPI;	Figure	3B).
To confirm the specificity of the effects of δ‐TT	on	ER	stress‐re‐
lated	proteins,	CRPC	cells	were	treated	with	the	tocotrienol	(15	μg/mL,	
24	hours),	 either	 in	 the	absence	or	 in	 the	presence	of	 two	ER	stress	
inhibitors:	 salubrinal	 (S,	 20	μM)	or	 4‐PBA	 (2	mM),	 for	 4	 and	1	hours,	
respectively.	Figure	3C	confirms	that	δ‐TT induces the expression of 
CHOP	and	ATF4	(as	in	Figure	3A);	pre‐treatment	with	both	ER	stress	
inhibitors significantly reduced the expression of both proteins. These 
results support that δ‐TT	triggers	ER	stress	in	CRPC	cells.
3.4 | ER stress mediates the antitumour activity of 
δ‐TT in prostate cancer cells
Data	from	the	literature	support	that	ER	stress	is	involved	in	the	antitu‐
mour activity of δ‐TT in cancer cells.29,30 To confirm this hypothesis in 
prostate	cancer	cells,	DU145	and	PC3	cells	were	treated	with	two	ER	
stress	inhibitors:	salubrinal	(20	μM)	or	4‐PBA	(2	mM),	for	4	and	1	hours,	
respectively,	before	δ‐TT	treatment	 (15	μg/mL,	24	hours).	δ‐TT mark‐
edly	 increased	the	expression	 levels	of	cleaved	caspase	3	and	PARP,	
confirming	 the	 results	 reported	 in	 Figure	 2A.	 Salubrinal	 and	 4‐PBA,	
given	alone,	did	not	modify	the	expression	of	these	proteins;	however,	
they significantly counteracted the effects of the tocotrienol on the ex‐
pression	of	the	cleaved	forms	of	both	caspase	3	and	PARP	(Figure	4A).
Figure	4B	shows	that	cell	viability	was	significantly	suppressed	
by δ‐TT	 treatment.	 Salubrinal	 and	 4‐PBA	 alone	 did	 not	 influence	
the	viability	of	cancer	cells;	however,	they	significantly	reverted	(al‐
though	not	 completely)	 the	 cytotoxic	 activity	of	δ‐TT,	 in	 both	 cell	
lines.	 These	 results	 demonstrate	 that	 ER	 stress	 is	 involved	 in	 the	
anti‐cancer activity of δ‐TT.
3.5 | δ‐TT triggers autophagy in PC3 prostate 
cancer cells
To assess whether δ‐TT might trigger the autophagy pathway in 
CRPC	cells,	DU145	and	PC3	cells	were	treated	with	δ‐TT	(15	μg/
mL,	1‐24	hours).	We	demonstrated	that	the	tocotrienol	markedly	
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increases the expression levels of the autophagy‐related proteins 
LC3‐II	 (increased	 LC3‐II/LC3‐I	 ratio)	 and	 SQSTM1/p62	 in	 PC3	
cells	 (at	6‐24	and	1‐24	hours	time	intervals,	respectively)	but	not	
in	DU145	 cells	 (Figure	 5A).	 In	 line	with	 this	 observation,	 by	 im‐
munofluorescence	analysis,	we	observed	that,	in	basal	conditions,	
LC3	is	poorly	expressed	in	both	cell	lines;	δ‐TT induced the cyto‐
plasmic	accumulation	of	LC3	(LC3	puncta)	and	p62	bodies	forma‐
tion	in	PC3	but	not	 in	DU145	cells	 (Figure	5B).	These	results	are	
in	agreement	with	data	reporting	that	DU145	cells	are	autophagy‐
defective	due	to	an	alternative	splicing	of	ATG5	transcript	and	lack	
of	a	full‐length	ATG5	protein.31	Thus,	further	studies	investigating	
the involvement of autophagy in δ‐TT anti‐cancer activity were 
performed	in	PC3	cells.
3.6 | δ‐TT triggers ER stress‐related autophagy in 
PC3 prostate cancer cells
To	confirm	the	activation	of	an	autophagic	flux	in	PC3	cells,	we	in‐
vestigated the presence of autophagosomes in δ‐TT‐treated	(15	μg/
mL,	18	hours)	cells	by	TEM.	Figure	6A	shows	that,	at	variance	with	
control	 cells	 (left	 panel),	 autophagosomes	 containing	 entire	 orga‐
nelles surrounded by multilamellar membranes are present in to‐
cotrienol‐treated	cells	(middle	panel,	boxed	area)	and	localize	at	the	
lysosomal level forming autophagolysosomes containing remnants 
of	digested	structures	(right	panel,	boxed	area).
Moreover,	 cells	 were	 pretreated	 with	 3‐MA	 (10	mM),	 or	 with	
CQ	(10	μM)	or	Baf	(10	nM)	and	then	with	the	tocotrienol	(15	μg/mL,	
24	hours).	Pre‐treatment	of	 the	 cells	with	3‐MA	 (inhibitor	of	early	
stage	autophagy)	inhibited	LC3‐II	expression	(decreasing	the	LC3‐II/
LC3‐I	ratio;	Figure	6B);	on	the	contrary,	CQ	and	Baf	(inhibitors	of	the	
late	phase	of	autophagy)	significantly	potentiated	the	effect	of	δ‐TT 
on	the	accumulation	of	LC3‐II	(LC3‐II/LC3‐1	ratio;	Figure	6C).
Similar results were obtained on the expression levels of 
SQSTM1/62	(Figure	6B,C).	Normally,	the	activation	of	autophagy	
determines	a	decrease	in	the	expression	of	SQSTM1/p62,	because	
of its accumulation in autophagosomes and the final degradation 
into	lysosomes.	However,	SQSTM1/p62	upregulation,	and	at	least	
transient	increases	in	the	amount	of	this	protein,	is	seen	in	some	
situations	where	 there	 is	an	 increase	 in	 its	 transcription	 (ie	 star‐
vation,	ER	stress).	The	results	obtained	indicate	that	the	levels	of	
SQSTM1/p62	are	elevated,	but	the	autophagic	flux	is	not	impaired.
To	assess	the	involvement	of	the	ER	stress	in	δ‐TT‐induced au‐
tophagy,	PC3	cells	were	pretreated	with	salubrinal	(20	μM,	4	hours)	
or	 4‐PBA	 (2	mM,	 1	hours),	 before	 treatment	with	δ‐TT	 (15	μg/mL,	
24	hours).	We	showed	that	both	ER	stress	 inhibitors	counteracted	
the	tocotrienol‐triggered	 increase	of	 the	LC3‐II/LC3‐I	 ratio	as	well	
as	that	of	SQSTM1/p62	expression	(Figure	6D,E).
In	 conclusion,	 in	 PC3	 cells	 (but	 not	 in	 autophagy‐defective	
DU145	cells),	δ‐TT‐induced autophagy is related to the upstream ac‐
tivation	of	the	ER	stress	pathways	(ER	stress‐autophagy	axis).
3.7 | Autophagy mediates the antitumour activity of 
δ‐TT in PC3 prostate cancer cells
To assess whether autophagy might mediate the proapoptotic 
activity of δ‐TT	 in	 PC3	 cells,	 cells	 were	 pretreated	 with	 3‐MA	
(10	mM,	4	hours)	before	δ‐TT	(15	μg/mL,	24	hours).	Caspase	3	and	
PARP	cleavage	and	cell	viability	were	 investigated	 (Western	blot	
F I G U R E  7   δ‐TT	triggers	paraptosis	in	prostate	cancer	cells.	In	all	these	experiments,	DU145	and	PC3	cells	were	treated	with	δ‐TT	(15	μg/
mL)	for	18	h.	A,	Light	microscopy	highlighting	the	presence	of	extensive	cytoplasmic	vacuolation	in	treated	cells.	Scale	bars	are	20	μm.	B,	
TEM	micrographs	showing	the	presence	of	swollen	damaged	mitochondria	(M),	with	loss	or	disintegrated	cristae	(mc)	and	endoplasmic	
reticulum	(ER)	cisternae	dilatation	(boxed	areas),	in	both	DU145	and	PC3	treated	cells.	Scale	bars	are	2	μm,	and	0.7	μm for photographs in 
boxed	areas.	C,	Light	microscopy	showing	that	pre‐treatment	of	DU145	and	PC3	cells	with	either	the	ER	stress	inhibitor	salubrinal	(S;	20	μM)	
for	4	h,	or	the	translation	inhibitor	cycloheximide	(20	μM)	for	3	h,	markedly	suppresses	cytoplasmic	vacuolation	in	δ‐TT‐treated prostate 
cancer cells. Scale bars are 20 μm
F I G U R E  8   δ‐TT increases the 
expression of proteins involved in the 
MAPK	cascade	in	prostate	cancer	cells.	
DU145	and	PC3	cells	were	treated	with	
δ‐TT	(15	μg/mL)	for	1‐24	h.	p‐JNK	and	p‐
p38	expression	levels	were	evaluated	by	
Western blot analysis. Tubulin expression 
was assessed as a loading control. 
One	representative	of	three	different	
experiments performed is shown
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and	MTT	assay).	Figure	6F	shows	that	δ‐TT increased the expres‐
sion	 of	 cleaved	 caspase	 3	 and	 PARP,	 as	 previously	 observed.	 3‐
MA,	given	alone,	did	not	affect	the	levels	of	these	proteins;	on	the	
other	hand,	3‐MA	significantly	counteracted	the	effects	of	δ‐TT on 
the	expression	levels	of	cleaved	caspase	3	and	PARP	(Figure	6F).
As	expected,	cell	viability	was	significantly	suppressed	by	δ‐TT,	
while	it	was	not	affected	by	3‐MA;	however,	the	autophagy	inhibitor	
significantly	reverted	(although	not	completely)	the	cytotoxic	effect	
of δ‐TT	(Figure	6G).
3.8 | δ‐TT triggers paraptosis in prostate cancer cells
Data	reported	above	suggest	that	δ‐TT may exert its activity by trig‐
gering non‐canonical pro‐death mechanisms in addition to apopto‐
sis	 (see	Figure	2C).	Paraptosis	 represents	an	alternative	cell	 death	
mechanism	 characterized	 by	 extensive	 vacuolation	 related	 to	 ER	
stress/mitochondria swelling.18,32,33 Paraptosis was also reported to 
be dependent on protein synthesis.34,35
We found that δ‐TT	(15	μg/mL,	18	hours)	induces	cytoplasmic	
vacuolation	in	both	DU145	and	PC3	cells	(Figure	7A).	By	TEM	anal‐
ysis,	we	observed	that	untreated	CRPC	cells	exhibit	a	normal	ap‐
pearance	with	normal	mitochondria	and	ER	with	small	profiles	of	
cisternae.	On	the	other	hand,	cells	treated	with	δ‐TT showed the 
presence of swollen damaged mitochondria with loss/altered cris‐
tae,	and	ER	cisternae	dilatation	(Figure	7B,	boxed	areas).	Moreover,	
pre‐treatment	of	CRPC	cells	with	the	ER	stress	inhibitor	salubrinal	
(20	μM,	 4	hours)	 markedly	 suppressed	 δ‐TT‐induced cytoplasmic 
vacuolation	(Figure	7C),	supporting	the	relationship	between	vacu‐
oles	and	ER	stress.	To	confirm	the	involvement	of	paraptosis	in	the	
anti‐cancer activity of δ‐TT,	DU145	and	PC3	cells	were	pretreated	
with	cycloheximide	(20	μM,	3	hours)	and	then	with	the	tocotrienol.	
Translation inhibition strikingly suppressed the cytoplasmic vacuo‐
lation induced by δ‐TT	in	both	cell	lines	(Figure	7C).
Finally,	the	effects	of	δ‐TT	(15	μg/ml,	1‐24	hours)	were	analysed	
on	the	expression	of	MAPK	proteins,	known	to	be	involved	in	parap‐
tosis. δ‐TT	(18	and	24	hours)	increased	the	levels	of	both	p‐JNK	and	
p‐p38	kinases	(Figure	8).
These data support that paraptosis is involved in the anti‐cancer 
activity of δ‐TT in prostate cancer cells.
4  | DISCUSSION
It	 is	 accepted	 that	 TTs	 are	 associated	with	 significant	 anti‐cancer	
properties.24,36	Although	most	of	the	studies	so	far	reported	were	
performed with γ‐TT,	δ‐TT was shown to be the most effective vi‐
tamin	E	isoform	in	triggering	cell	death	in	prostate	cancer	cells37,38; 
however,	 the	 molecular	 mechanisms/targets	 of	 this	 activity	 are	
poorly clarified.
Here,	 we	 dissected	 the	 molecular	 mechanisms	 underlying	 the	
antitumour/proapoptotic activity of δ‐TT	in	CRPC	cells	(DU145	and	
PC3);	the	possible	involvement	of	paraptosis	in	its	activity	was	also	
investigated.
We confirmed that δ‐TT exerts a significant antitumour/cyto‐
toxic	activity	on	CRPC	cells,	by	decreasing	cell	viability,	 increasing	
the dead/live cells ratio and reducing the viability of colony‐forming 
cells.	Interestingly,	the	tocotrienol	reduced	the	viability	of	RWPE‐1	
cells only slightly and at the highest dose. We also demonstrated that 
δ‐TT	triggers	apoptosis	by	increasing	the	levels	of	cleaved	caspase	3	
and	PARP	and	 releasing	cytochrome	c from mitochondria into the 
cytoplasm. We finally confirmed the involvement of the intrinsic 
apoptosis in the activity of δ‐TT by showing that pre‐treatment of 
the	 cells	 with	 the	 pan‐caspase	 inhibitor	 Z‐VAD‐FMK	 significantly	
counteracts its cytotoxic effects.
These data agree with previous observations showing that δ‐TT 
induces cell death in prostate cancer cells37,38 and suppresses the 
survival	of	the	stem‐like	cells	subpopulation	of	PC3	cells40; similar 
results were reported for γ‐TT.24,41,42
In	 line	with	 these	data,	 the	anti‐cancer	activity	of	TTs	 (specifi‐
cally γ‐ and δ‐TT)	was	reported	in	a	wide	range	of	tumours.24,45,46
To get further insights into the mechanisms and targets of the 
δ‐TT	antitumour	activity	 in	CRPC	cells,	we	concentrated	our	stud‐
ies	 on	 the	ER	 stress	 and	 autophagy	pathways.	We	observed	 that,	
in	both	DU145	and	PC3	cells,	δ‐TT	 induces	 the	expression	of	BiP,	
p‐eIF2α	and	IRE1α. δ‐TT also induced the expression/activation of 
the	transcription	factors	ATF4	and	CHOP	(pointing	out	their	cyto‐
plasmic‐to‐nuclear	 localization).	 It	 is	known	that	 the	p‐eIF2α/ATF4	
pathway	activates	CHOP,	a	transcription	factor	that	is	also	activated	
by	 IRE1α.14,51	These	 results	demonstrate	 that,	 in	CRPC	cells,	δ‐TT 
triggers	 the	main	 ER	 stress	 branches,	 leading	 to	 the	 activation	 of	
CHOP,	deeply	 involved	 in	the	ER	stress‐related	apoptosis.	To	con‐
firm	the	involvement	of	the	ER	stress	pathway	in	the	activity	of	δ‐TT,	
we	pretreated	the	cells	with	two	ER	stress	inhibitors,	salubrinal	and	
4‐PBA.	Both	inhibitors	significantly	reverted	the	proapoptotic	effect	
of δ‐TT,	as	assessed	in	terms	of	cleavage	of	caspase	3	and	PARP	as	
well	as	of	cell	viability,	indicating	that	ER	stress	mediates	its	anti‐can‐
cer activity.
We also investigated whether autophagy might be induced by 
δ‐TT	 in	 CRPC	 cells.	 First,	we	 demonstrated	 that	 the	 tocotrienol	
markedly	increases	the	expression	of	autophagy‐related	proteins,	
such	as	LC3	(increased	LC3‐II/LC3‐I	ratio)	and	SQSTM1/p62	and	
their	accumulation	into	autophagosomes	in	PC3,	but	not	in	DU145	
cells	(previously	reported	to	be	autophagy‐defective).31	Thus,	the	
involvement of autophagy in the antitumour activity of δ‐TT was 
further	 investigated	 in	PC3	cells.	By	TEM,	we	demonstrated	 the	
presence of autophagosomes and autophagolysosomes in δ‐TT‐
treated cells. Pre‐treatment of the cells with an early stage au‐
tophagy	 inhibitor	 (3‐MA)	 significantly	 counteracted,	 while	 their	
pre‐treatment	with	 late	stage	autophagy	 inhibitors	 (CQ	and	Baf)	
markedly increased δ‐TT‐induced	 LC3‐II	 and	 SQSTM1/p62	 ex‐
pression. These data support that δ‐TT triggers an autophagic 
flux	in	PC3	cancer	cells.	We	further	showed	that	in	PC3	cells,	the	
autophagy	 pathway	 is	 linked	 to	 ER	 stress,	 since	 pre‐treatment	
of	 the	 cells	with	 the	 ER	 stress	 inhibitors	markedly	 prevented	 δ‐
TT‐induced	 LC3‐II	 and	SQSTM1/p62	overexpression.	 Finally,	we	
demonstrated	 that	 the	 autophagy	 inhibitor	 3‐MA	 significantly	
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counteracts the effects of δ‐TT on apoptosis markers as well as 
on cell viability.
These	data	demonstrate	that,	 in	CRPC	cells	possessing	an	effi‐
cient	autophagy	pathway,	δ‐TT induces apoptosis by triggering the 
ER	stress‐related	pro‐death	autophagy	pathway.	On	the	other	hand,	
only	the	ER	stress	pathway	is	involved	in	the	activity	of	δ‐TT in auto‐
phagy‐defective cells.
To	 our	 knowledge,	 this	 is	 the	 first	 report	 describing	 the	 in‐
volvement	of	the	ER	stress‐autophagy	in	the	anti‐cancer	activity	
of δ‐TT in prostate cancer cells. γ‐TT was shown to concurrently 
trigger	 ER	 stress	 and	 autophagy	 in	 inducing	 apoptosis	 in	 breast	
cancer cells.52,53	TTs	(specifically	γ‐ and δ‐TT)	were	shown	to	 in‐
duce	 apoptosis	 by	 triggering	 the	 ER	 stress	 branches	 in	 cervical	
cancer,30 breast cancer54 and melanoma cells.29	In	line	with	these	
observations,	 both	 the	 ER	 stress	 and	 the	 autophagy	 pathways	
were reported to mediate the anti‐cancer activity of several natu‐
ral compounds.55,56
Here,	we	also	observed	that	abrogation	of	apoptosis	by	the	pan‐
caspase	 inhibitor	 Z‐VAD‐FMK	 significantly,	 but	 not	 completely,	 re‐
verted the cytotoxic effect of δ‐TT	on	CRPC	cells.	Thus,	an	additional	
programmed cell death modality might be involved in the activity of 
the	tocotrienol.	Paraptosis,	necroptosis,	mitotic	catastrophe,	anoikis	
were reported to be typical of apoptosis‐resistant tumour cells and to 
mediate the cytotoxic effects of anti‐cancer compounds.18,20,33 This 
makes these types of cell death a promising target for novel ther‐
apeutic strategies.33	 Among	 them,	 paraptosis	 is	 characterized	 by:	
intense	cytoplasmic	vacuolation,	correlated	with	ER	stress	and	mito‐
chondrial swelling/dilatation; de novo protein synthesis; involvement 
of	JNK	and	p38	kinases.18,21,33 We observed that δ‐TT induces mor‐
phological	changes,	with	an	intense	cytoplasmic	vacuolation	in	both	
CRPC	cells.	In	δ‐TT‐treated	cells,	we	pointed	out:	by	TEM,	a	signifi‐
cant	swelling	of	mitochondria	and	dilatation	of	the	ER	cisternae;	by	
light	microscopy,	a	cytoplasmic	vacuolation	that	was	markedly	inhib‐
ited	in	the	presence	of	salubrinal	or	cycloheximide;	by	Western	blot,	
increased	expression	of	the	active	forms	of	JNK	and	p38.	These	data	
support	 that,	 in	addition	to	apoptosis,	 the	non‐canonical	cell	death	
paraptosis is involved in the antitumour activity of δ‐TT in CRPC cells. 
So	far,	the	role	of	paraptosis‐like	cell	death	in	the	cytotoxic	activity	
of δ‐TT has been reported only in colon carcinoma cells.62,63	On	the	
other	hand,	different	natural	compounds	(such	as	taxol)	were	shown	
to trigger this cell death in different cancer cells.18,64,65
These	data	demonstrate	that,	in	CRPC	cells,	δ‐TT exerts an anti‐
cancer	activity	by	triggering	both	apoptosis,	involving	the	ER	stress‐
autophagy	axis,	and	paraptosis,	providing	novel	mechanistic	insights	
into this activity.
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